Last reviewed · How we verify
Insulin Detemir, Insulin Insulatard — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Insulin Detemir, Insulin Insulatard (Insulin Detemir, Insulin Insulatard) — Rigshospitalet, Denmark.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Insulin Detemir, Insulin Insulatard TARGET | Insulin Detemir, Insulin Insulatard | Rigshospitalet, Denmark | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Insulin Detemir, Insulin Insulatard CI watch — RSS
- Insulin Detemir, Insulin Insulatard CI watch — Atom
- Insulin Detemir, Insulin Insulatard CI watch — JSON
- Insulin Detemir, Insulin Insulatard alone — RSS
Cite this brief
Drug Landscape (2026). Insulin Detemir, Insulin Insulatard — Competitive Intelligence Brief. https://druglandscape.com/ci/insulin-detemir-insulin-insulatard. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab